The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey

The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey

Abstract Background Withholding live-attenuated vaccines in patients using interleukin (IL)-1 or IL-6 blocking agents is recommended by guidelines for both pediatric and adult rheumatic diseases, since there is a risk of infection in an immune suppressed host. However, this has never been studied. T...

Full description

Bibliographic Details
Main Authors: Jerold Jeyaratnam, Nienke M. ter Haar, Helen J. Lachmann, Ozgur Kasapcopur, Amanda K. Ombrello, Donato Rigante, Fatma Dedeoglu, Ezgi H. Baris, Sebastiaan J. Vastert, Nico M. Wulffraat, Joost Frenkel
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Autoinflammatory diseases
Live-attenuated vaccines
Biologicals
IL-1 blockade
IL-6 blockade
Online Access:http://link.springer.com/article/10.1186/s12969-018-0235-z

Internet

http://link.springer.com/article/10.1186/s12969-018-0235-z

Similar Items